Program
Liraglutide
Also written as “liraglutide”, “insulin degludec/liraglutide” and “Insulin degludec/liraglutide”.
Its studies are mostly in Diabetes Mellitus, Type 2 · Obesity · Diabetes Mellitus · Diabetes Mellitus, Type 1 · Osteoarthritis, Knee, led by 10 companies.
Drug pageLiraglutide: every studyMany companies study it; this page follows only the 109 they lead. All 336 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Novo Nordisk | 972 open or running | phase 4since Jul 22, 2013 | Sep 8, 2005 | Dec 13, 2026phase 1 · NCT07225816 |
| 4Moving Biotechits history only | 20 open or running | phase 2since Sep 24, 2025 | Jun 7, 2022 | none ahead |
| Eli Lillyits history only | 20 open or running | phase 4since Feb 24, 2014 | May 31, 2013 | none ahead |
| Tonghua Dongbao Pharmaceuticalits history only | 22 open or running | phase 3since Aug 14, 2024 | Jun 2, 2024 | none ahead |
| Biolingusits history only | 11 open or running | phase 2since Feb 16, 2022 | Feb 16, 2022 | none ahead |
| Cinnagenits history only | 10 open or running | phase 3since Jan 29, 2018 | Jan 29, 2018 | none ahead |
| ikfe-CROits history only | 10 open or running | phase 4since Sep 17, 2010 | Sep 17, 2010 | none ahead |
| Merckits history only | 10 open or running | phase 1since Jun 13, 2011 | Jun 13, 2011 | none ahead |
| Pfizerits history only | 10 open or running | phase 1since Feb 1, 2017 | Feb 1, 2017 | none ahead |
| Sino Biopharmaceuticalits history only | 10 open or running | phase 1since Aug 24, 2021 | Aug 24, 2021 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Novo Nordisk only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 41 studies since Jan 6, 2012.
- May 11, 2015Phase 2 study in Diabetes MellitusNCT02443155 · 308 enrolled · United States, Austria, Belgium and more
- Jul 15, 20152 phase 3 studies in Diabetes MellitusNCT02501161, NCT02505334
- Aug 17, 2015Phase 3 study in Nutrition DisordersNCT02527200 · 56 enrolled · United States, Australia, Canada and more
- Nov 16, 2015Phase 3 study in Diabetes MellitusNCT02607306 · 819 enrolled · Japan
- Feb 26, 2016Phase 1 study in Nutrition DisordersNCT02696148 · 24 enrolled · United States
- Mar 15, 2016Phase 1 study in Nutrition DisordersNCT02717858 · 52 enrolled · Denmark
- Mar 23, 2016Phase 4 study in Diabetes MellitusNCT02730377 · 1,991 enrolled · United States, Canada, Colombia and more
- May 13, 2016Phase 3 study in Diabetes MellitusNCT02773368 · 420 enrolled · United States, Argentina, Canada and more
- Sep 20, 20162 phase 3 studiesNCT02911948, NCT02918279
- Nov 10, 20163 phase 3 studiesNCT02963935, NCT02963922, NCT02964247
- May 24, 20172 phase 3 studies in Diabetes MellitusNCT03175120, NCT03172494
- Sep 19, 2017Phase 1 study in Diabetes MellitusNCT03292185 · 24 enrolled · China
- Feb 26, 2021Phase 3 study in ObesityNCT04775082 · 82 enrolled · United States, Belgium, India and more
- Nov 5, 2025Phase 1 study in ObesityNCT07225816 · 71 planned · United States
Ahead
- Dec 13, 2026Primary completion: phase 1 study in ObesityNCT07225816
TargetBeta
“Glucagon-like peptide 1 receptor agonist”ChEMBL 37, by rule
Other programs on GLP1R
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| Semaglutiderule | Novo Nordisk | phase 4 | 170 |
| Tirzepatiderule | Eli Lilly | phase 4 | 72 |
| dulaglutiderule | Eli Lilly | phase 4 | 47 |
| orforglipronrule | Eli Lilly | phase 3 | 50 |
| zenagamtide | Novo Nordisk | phase 3 | 36 |
| survodutide | Boehringer Ingelheim | phase 3 | 35 |
| retatrutiderule | Eli Lilly | phase 3 | 33 |
| mazdutiderule | Innovent Biologics | phase 3 | 27 |
| bofanglutiderule | Gan & Lee Pharmaceuticals | phase 3 | 25 |
| berobenatide | Pfizer | phase 3 | 23 |
| brenipatide | Eli Lilly | phase 3 | 19 |
| Safiglipron | Jiangsu HengRui Medicine | phase 3 | 19 |
Studies
The newest 60 of 97 Novo Nordisk leads. Each opens its study page. Every study on its drug page →
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07225816Obesity · United States | 1 | Recruiting | Dec 13, 2026 | 71 |
| NCT04775082Obesity · United States, Belgium, India and more | 3 | Active, not recruiting | Aug 1, 2023 | 82 |
| NCT03292185Diabetes Mellitus · China | 1 | Completed | Jan 2, 2018 | 24 |
| NCT03175120Diabetes Mellitus · China, Hong Kong | 3 | Completed | Mar 5, 2019 | 453 |
| NCT03172494Diabetes Mellitus · China | 3 | Completed | Jun 14, 2019 | 720 |
| NCT02964247Diabetes Mellitus · United States, Brazil, India and more | 3 | Completed | May 4, 2018 | 303 |
| NCT02963935Nutrition Disorders · United States | 3 | Completed | May 23, 2018 | 282 |
| NCT02963922Nutrition Disorders · United States, Canada, Germany and more | 3 | Completed | Sep 10, 2018 | 396 |
| NCT02918279Nutrition Disorders · United States, Belgium, Mexico and more | 3 | Completed | Feb 14, 2019 | 251 |
| NCT02911948Diabetes Mellitus · Japan | 3 | Completed | Nov 17, 2017 | 210 |
| NCT02773368Diabetes Mellitus · United States, Argentina, Canada and more | 3 | Completed | Sep 26, 2017 | 420 |
| NCT02730377Diabetes Mellitus · United States, Canada, Colombia and more | 4 | Completed | Aug 5, 2019 | 1,991 |
| NCT02717858Nutrition Disorders · Denmark | 1 | Completed | Feb 27, 2017 | 52 |
| NCT02696148Nutrition Disorders · United States | 1 | Completed | Apr 13, 2017 | 24 |
| NCT02607306Diabetes Mellitus · Japan | 3 | Completed | Dec 15, 2017 | 819 |
| NCT02527200Nutrition Disorders · United States, Australia, Canada and more | 3 | Completed | Nov 4, 2020 | 56 |
| NCT02505334Diabetes Mellitus · Japan | 3 | Completed | May 2, 2017 | 635 |
| NCT02501161Diabetes Mellitus · United States, Argentina, Brazil and more | 3 | Completed | Oct 3, 2018 | 1,012 |
| NCT02443155Diabetes Mellitus · United States, Austria, Belgium and more | 2 | Completed | Aug 31, 2018 | 308 |
| NCT02420262Diabetes Mellitus · United States, Argentina, Czechia and more | 3 | Completed | Oct 5, 2016 | 506 |
| NCT02298192Diabetes Mellitus · United States, Austria, Bulgaria and more | 3 | Completed | Dec 23, 2015 | 420 |
| NCT02207348Nutrition Disorders · Germany | 1 | Completed | Sep 2014 | 24 |
| NCT02100475Diabetes Mellitus · United States, Argentina, Australia and more | 3 | Completed | Apr 2015 | 31 |
| NCT02098395Diabetes Mellitus · United States, Austria, Belgium and more | 3 | Completed | Apr 2015 | 835 |
| NCT02008682Diabetes Mellitus · China | 4 | Completed | Nov 2014 | 368 |
| NCT01973231Diabetes Mellitus · Czech Republic, Finland, France and more | 4 | Completed | Nov 2014 | 404 |
| NCT01952145Diabetes Mellitus · United States, Argentina, Australia and more | 3 | Completed | Nov 4, 2014 | 557 |
| NCT01916174Diabetes Mellitus · Germany | 1 | Completed | Nov 2013 | 50 |
| NCT01917656Diabetes Mellitus · Algeria, India, Israel and more | 4 | Completed | Sep 1, 2014 | 343 |
| NCT01907854Diabetes Mellitus · United States, Canada, Hungary and more | 4 | Completed | Jun 15, 2015 | 407 |
| NCT01836523Diabetes Mellitus · United States, Argentina, Australia and more | 3 | Completed | Jun 2015 | 1,398 |
| NCT01789086Nutrition Disorders · Germany | 1 | Completed | May 2014 | 21 |
| NCT01620489Diabetes Mellitus · United States, France, Poland and more | 3 | Completed | Aug 20, 2013 | 279 |
| NCT01620476Diabetes Mellitus · Japan | 1 | Completed | Mar 2004 | 24 |
| NCT01620463Diabetes Mellitus · Japan | 1 | Completed | Mar 2003 | 32 |
| NCT01617434Diabetes Mellitus · United States, Argentina, Canada and more | 3 | Completed | Oct 2013 | 451 |
| NCT01615978Diabetes Mellitus · Japan | 1 | Completed | Mar 2004 | 15 |
| NCT01572740Diabetes Mellitus · Japan | 3 | Completed | Nov 1, 2012 | 257 |
| NCT01557166Nutrition Disorders · United States, Canada | 3 | Completed | Jun 1, 2013 | 359 |
| NCT01541215Diabetes Mellitus · United States, Australia, Austria and more | 3 | Completed | Nov 15, 2017 | 135 |
| NCT01536665Diabetes Mellitus · Austria | 1 | Completed | Aug 2012 | 45 |
| NCT01517568Diabetes Mellitus · Netherlands | 1 | Completed | Dec 2006 | 7 |
| NCT01517555Diabetes Mellitus · Germany | 1 | Completed | May 2007 | 18 |
| NCT01516255Diabetes Mellitus · United States | 1 | Completed | Nov 2006 | 64 |
| NCT01515592Diabetes Mellitus · Japan | 1 | Completed | Apr 2006 | 24 |
| NCT01515579Diabetes Mellitus · Sweden | 1 | Completed | Jun 2006 | 22 |
| NCT01515553Diabetes Mellitus · Sweden | 1 | Completed | Apr 2007 | 22 |
| NCT01518166Diabetes Mellitus · Sweden | 1 | Completed | Apr 2007 | 70 |
| NCT01514487Diabetes Mellitus · Australia | 1 | Completed | Mar 30, 2005 | 24 |
| NCT01513525Diabetes Mellitus · Germany | 1 | Completed | May 2007 | 21 |
| NCT01511692Diabetes Mellitus · Australia, Germany | 1 | Completed | Sep 2007 | 43 |
| NCT01511198Diabetes Mellitus · United States | 2 | Completed | Oct 2001 | 223 |
| NCT01511185Diabetes Mellitus · United States | 1 | Completed | Oct 2001 | 20 |
| NCT01511172Diabetes Mellitus · Australia, Austria, Czech Republic and more | 2 | Completed | Dec 2002 | 145 |
| NCT01511159Diabetes Mellitus · United Kingdom | 1 | Completed | Dec 2001 | 32 |
| NCT01512108Diabetes Mellitus · Japan | 3 | Completed | Apr 26, 2013 | 363 |
| NCT01508949Diabetes Mellitus · Denmark | 2 | Completed | Mar 2002 | 35 |
| NCT01508923Diabetes Mellitus · Denmark | 2 | Completed | Feb 2002 | 17 |
| NCT01509755Diabetes Mellitus · Denmark, Norway, Sweden and more | 2 | Completed | Oct 2001 | 196 |
| NCT01509742Diabetes Mellitus · Germany | 1 | Completed | Nov 2001 | 19 |
How it is read
Names in the registry
- “liraglutide”, 114 entries
- “insulin degludec/liraglutide”, 11 entries
- “Liraglutide”, 10 entries
- “Insulin degludec/liraglutide”, 3 entries
- “NN9924 (oral)”, 2 entries
Conditions, from the studies’ own filings
- Diabetes Mellitus, Type 2, 75 studies
- Obesity, 18 studies
- Diabetes Mellitus, 14 studies
- Diabetes Mellitus, Type 1, 5 studies
- Osteoarthritis, Knee, 2 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.